[Pharmaco-erection in erectile deficiency after surgical therapy].
This report emphasizes the fact that the patients operated show a bigger motivation in facing the problem of erectile deficit; this motivation lacks in patients treated with chemotherapy, radiotherapy and hormonotherapy. The results are anyway very interesting because the pharmacology prosthesis is generally well accepted and tolerated; very rare are the complications.
Favre
M
M
UB Urologia Modulo di Andrologia, Ospedale Regionale Valle d'Aosta.
Enria
T
T
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use; D015653:Cystectomy / Q000009:adverse effects*; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007267:Injections; D008297:Male; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use; D015917:Penile Prosthesis; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use; D011468:Prostatectomy / Q000009:adverse effects*; D013737:Testis; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine
Farmacoerezione nei deficit erettili post-terapia chirurgica.